MNPR
Biotechnology · Healthcare
CFO, Chief Accounting Officer
2024-07-01–present
Chief Accounting Officer
Monopar Therapeutics (MNPR)Equibles does not estimate personal net worth.
Get an email with a short summary when Monopar Therapeutics publishes a filing, an earnings call transcript or a press release.
Get MNPR alertsKarthik Radhakrishnan is recorded as CFO and Chief Accounting Officer at Monopar Therapeutics (MNPR) since July 1, 2024. Monopar Therapeutics reported in an 8-K filed March 3, 2025 that Karthik Radhakrishnan was terminated as Chief Financial Officer, effective February 28, 2025. Monopar Therapeutics reported in an 8-K filed May 24, 2024 that Karthik Radhakrishnan was appointed Chief Financial Officer, effective July 1, 2024. The proxy statement of Monopar Therapeutics reports total compensation of $320,160 for Karthik Radhakrishnan in fiscal 2024, including a base salary of $192,400. Disclosed compensation is on record for 2 fiscal years. Monopar Therapeutics is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Monopar Therapeutics includes Chandler D. Robinson (CEO and Board Member), Quan A. Vu (CFO), Quan Vu (CFO and Chief Accounting Officer) and 7 others.
“On February 28, 2025, Karthik Radhakrishnan’s employment with Monopar Therapeutics Inc. (the “Company” or “Monopar”) terminated.”
“On May 23, 2024, the Company's Board of Directors appointed, Karthik Radhakrishnan, age 53, to succeed Ms. Tsuchimoto as Monopar's Chief Financial Officer, principal accounting officer and principal financial officer effective July 1, 2024.”
2024-07-01–present
2024-07-01–present
2024-07-01–2025-02-28
Start not stated–2025-02-28
MNPR
Biotechnology · Healthcare
CFO, Chief Accounting Officer
2024-07-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Monopar Therapeutics (MNPR) | Former Chief Financial Officer, Secretary, and Treasurer | $192,400 | $320,160 |
| 2023 | Monopar Therapeutics (MNPR) | Former Chief Financial Officer, Secretary, and Treasurer | — | — |